6 results

• Pradaxa Antidote Receives Full FDA Approval for Reversal of Bleeding Problems

  April 20, 2018

  Irvin Jackson

  The FDA has granted full approval for the Pradaxa reversal agent, Praxbind, following positive results from phase III clinical trials.

• Pradaxa Reversal Agent Praxbind Found To Be Effective In New Study

  July 19, 2017

  Irvin Jackson

  The reversal agent for Pradaxa, Praxbind, appears to be working as it should and quickly cancelling the drug's blood thinning effects in nearly all patients, according to the findings of a new study.

• Pradaxa Risk for Bleeding Increased When Used With Zocor, Mevacor and Altoprev: Study

  November 22, 2016

  Irvin Jackson

  The findings of a new study indicate that combining the blood thinner Pradaxa with the cholesterol drugs Zocor, Mevacor and Altoprev can significantly increase the risk of serious bleeding events in patients 66 years of age and older.

• Praxbind Available to Help Stop Pradaxa Bleeding Problems at Hospitals Nationwide

  March 10, 2016

  Irvin Jackson

  A reversal agent for the blood thinner Pradaxa is now available nationwide after thousands of bleeding events and lawsuits.

• Pradaxa Emergency Bleeding Problems Can Be Addressed With Praxbind Reversal Agent: FDA

  October 19, 2015

  Austin Kirk

  The FDA has approved a reversal agent for the blood thinner Pradaxa called Praxbind, which is supposed to stop the drug's blood thinning effects in patients suffering a bleeding emergency.

• Pradaxa Reversal Agent Gets Positive Review From European Regulators

  October 5, 2015

  Irvin Jackson

  Pradaxa is close to having a reversal agent approved in Europe, which may give it an edge over other blood thinner competitors.